The production market for nano-based drug delivery systems is expected to grow steadily from 2024 to 2031. Key players in the market include Amgen, Teva, Roche, UCB, and more. The market is driven by precision targeting, biomimicry, digital health, and sustainability.
The nanoparticles market is projected to exhibit a CAGR of 6% from 2022 to 2029, with key players like Gilead Sciences and Amgen driving growth in industries ranging from pharmaceuticals to electronics. The global advanced drug delivery systems market is experiencing significant growth due to the increasing prevalence of chronic diseases and advancements in drug formulation technologies.
The market is expected to grow at a CAGR of 7.50% from 2024 to 2031, with key players like AstraZeneca and 3M contributing to its evolution. The biosimilars market is set to generate new growth opportunities, driven by rising approvals and focus on complex drugs.
Key players in this market include Amgen, Pfizer, Samsung Bioepis, and more. The global drug discovery CRO production market is growing rapidly, fueled by increased outsourcing and AI/automation.
Key players in this market include Charles River, Wuxi Apptec, Eurofins Scientific, and more. The botanical and plant-derived drugs market is driven by rising consumer preference for natural remedies and increased R&D investments.
Key players in this market include Abbott Laboratories, Bayer Healthcare, Bionova, and more. Lastly, experts in nanomedicine development have presented early-stage recommendations to streamline the translation of nanomedicines from the lab to the clinic, addressing design, manufacturing, and regulatory challenges.
